Vaxcyte, Inc. (PCVX) dividend history

PCVXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30

$64.69−3.93 (-5.73%)

Close on Nov 12, 2026Market cap $9.63BP/E –Yield 0.00%

Dividends

No dividend per share appears in Vaxcyte's annual filings since fiscal 2017.

See a number that looks wrong?